0
0
0
Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act
7/24/2024, 3:13 PM
Summary of Bill HR 2365
Bill 118 hr 2365, also known as the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act, is a piece of legislation introduced in the US Congress with the goal of creating a national plan to combat Parkinson's disease. The bill is named after Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton, who are both advocates for Parkinson's research and treatment.
The main objective of the bill is to establish a comprehensive strategy to address the challenges faced by individuals living with Parkinson's disease. This includes improving access to care, increasing funding for research, and promoting education and awareness about the disease. The bill also aims to enhance coordination among federal agencies, healthcare providers, and advocacy organizations to ensure a unified approach to tackling Parkinson's.
Additionally, the bill calls for the creation of a Parkinson's Disease Council, which will be responsible for developing and implementing the national plan. The council will consist of experts in the field of Parkinson's research, healthcare providers, and individuals living with the disease. Overall, the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act seeks to improve the quality of life for individuals affected by Parkinson's disease and ultimately work towards finding a cure. It represents a bipartisan effort to address a pressing public health issue and highlights the importance of collaboration and innovation in the fight against Parkinson's.
The main objective of the bill is to establish a comprehensive strategy to address the challenges faced by individuals living with Parkinson's disease. This includes improving access to care, increasing funding for research, and promoting education and awareness about the disease. The bill also aims to enhance coordination among federal agencies, healthcare providers, and advocacy organizations to ensure a unified approach to tackling Parkinson's.
Additionally, the bill calls for the creation of a Parkinson's Disease Council, which will be responsible for developing and implementing the national plan. The council will consist of experts in the field of Parkinson's research, healthcare providers, and individuals living with the disease. Overall, the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act seeks to improve the quality of life for individuals affected by Parkinson's disease and ultimately work towards finding a cure. It represents a bipartisan effort to address a pressing public health issue and highlights the importance of collaboration and innovation in the fight against Parkinson's.
Congressional Summary of HR 2365
Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson's Act
This bill requires the Department of Health and Human Services (HHS) to carry out a project to address Parkinson's disease (a progressive brain disorder that causes unintended or uncontrollable movements) and related conditions.
Among other components of the project, HHS must (1) implement and periodically update a national plan to coordinate and guide efforts to prevent, diagnose, treat, and cure the disease; and (2) improve the care of those with the disease. HHS must also annually assess the preparations for and response to the increased burden of Parkinson's disease.
In addition, the bill establishes a council, comprised of federal and nonfederal stakeholders, to advise HHS on and make recommendations concerning the prevention and treatment of Parkinson's disease.
The provisions of the bill terminate at the end of calendar year 2035.
Read the Full Bill
Current Status of Bill HR 2365
Bill HR 2365 is currently in the status of Signed by President since July 2, 2024. Bill HR 2365 was introduced during Congress 118 and was introduced to the House on March 29, 2023. Bill HR 2365's most recent activity was Became Public Law No: 118-66. as of July 2, 2024
Bipartisan Support of Bill HR 2365
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
344Democrat Cosponsors
230Republican Cosponsors
114Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 2365
Primary Policy Focus
HealthPotential Impact Areas
- Advisory bodies
- Congressional oversight
- Government information and archives
- Health promotion and preventive care
- Neurological disorders
Alternate Title(s) of Bill HR 2365
Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act
Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act
Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act
National Plan to End Parkinson’s Act
Dr. Emmanuel Bilirakis National Plan to End Parkinson’s Act
Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act
To direct the Secretary of Health and Human Services to carry out a national project to prevent and cure Parkinson's, to be known as the National Parkinson's Project, and for other purposes.
To direct the Secretary of Health and Human Services to carry out a national project to prevent, diagnose, treat, and cure Parkinson's, to be known as the National Parkinson's Project, and for other purposes.
Comments
Sponsors and Cosponsors of HR 2365
Latest Bills
Vote Without Fear Act
Bill HR 7965March 31, 2026
To authorize the Department of Commerce to carry out a study on challenges faced by United States small artificial intelligence businesses, and for other purposes.
Bill HR 7968March 31, 2026
To amend the Export Control Reform Act of 2018 relating to the review of the interagency dispute resolution process.
Bill HR 7962March 31, 2026
To amend the Foreign Intelligence Surveillance Act of 1978 to implement reforms, to amend title 18, United States Code, to prevent law enforcement and intelligence agencies from obtaining certain commercially available information, and for other purposes.
Bill HR 7816March 31, 2026
To establish a grant program to provide schools with opioid overdose reversal drugs, to direct schools receiving Federal funds to report to certain Federal information systems any distribution of an opioid overdose reversal drug, and for other purposes.
Bill HR 7994March 31, 2026
To amend the Homeland Security Act of 2002 to clarify that utility line technicians qualify as emergency response providers.
Bill HR 7996March 31, 2026
To require the Secretary of the Treasury to submit to Congress a comprehensive report on barriers to Somaliland's access to the United States financial system, and for other purposes.
Bill HR 7993March 31, 2026
To amend the Richard B. Russell National School Lunch Act to provide additional reimbursement to schools with a breakfast after the bell program, and for other purposes.
Bill HR 7999March 31, 2026
To require the Secretary of Health and Human Services to revise the Mandatory Guidelines for Federal Workplace Drug Testing Programs to include testing for methadone use and to require the Secretary of Transportation to issue regulations to include testing for methadone use in Department of Transportation drug tests.
Bill HR 7967March 31, 2026
CANS Act of 2026
Bill HR 7992March 31, 2026
National Plan to End Parkinson’s Act
Bill S 1064December 15, 2023